Skip to main content

Find Clinical Trials

Home
Conditions
Slow Virus Diseases

Clinical trial condition

Slow Virus Diseases

Explore clinical trials studying Slow Virus Diseases. Study availability and eligibility vary by location and protocol.

2,616 public trials 184 recruiting studies

Refine in advanced search Browse all conditions

Slow Virus Diseases trial results

Completed

AVX754 (a New Nucleoside Reverse Transcriptase Inhibitor [NRTI]) to Treat Drug-resistant HIV

NCT00126880

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +13 more
Locations: Avexa (co-ordinating sites in Australia and Argentina) Melbourne, Victoria, Australia

View Trial Details

Completed

TMC125-TiDP2-C187: A Phase I, Open-label Trial to Investigate the Pharmacokinetic Interaction Between TMC125 and Two Antifungal Agents (Fluconazole and Voriconazole), All at Steady-state in Healthy Subjects.

NCT00740389

Conditions: AIDS, Acquired Immunodeficiency Syndrome, Bacterial Infections and Mycoses, +18 more
Locations: Not specified

View Trial Details

Completed

TMC114-TiDP3-C181: Study to Assess the Pharmacokinetics of Darunavir (DRV) With Different Doses of Ritonavir in Healthy Volunteers.

NCT00744887

Conditions: AIDS, Acquired Immunodeficiency Syndrome, Blood-Borne Infections, +15 more
Locations: Not specified

View Trial Details

Completed

Raltegravir With Optimized Background Therapy (OBT) in Multiple Experienced HIV-infected Patients

NCT01190124

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +13 more
Locations: Not specified

View Trial Details

Completed

An Open-Label Study to Evaluate the Effect of Every Other Week PROCRIT� (Epoetin Alfa) Dosing (40,000-60,000 Units) On Maintaining Quality of Life and Target Hemoglobin Levels in Anemic HIV-Infected Patients (CHAMPS II)

NCT00317902

Conditions: Acquired Immunodeficiency Syndrome, Anemia, Blood-Borne Infections, +16 more
Locations: Not specified

View Trial Details

Completed

A Study to Evaluate the Safety and Effectiveness of Epoetin Alfa in AIDS (Acquired Immunodeficiency Syndrome) Patients With Anemia Caused Both by Their Disease and by AZT (Zidovudine, an Antiviral Drug) Given as Treatment for Their Disease

NCT00270010

Conditions: Acquired Immunodeficiency Syndrome, Anemia, Blood-Borne Infections, +16 more
Locations: Not specified

View Trial Details

Completed

A Study to Evaluate the Safety and Efficacy of Epoetin Alfa Versus Placebo for the Treatment of Anemia in AIDS (Acquired Immunodeficiency Syndrome) Patients With Anemia Caused by the Disease and by Zidovudine (AZT) Therapy

NCT00270270

Conditions: Acquired Immunodeficiency Syndrome, Anemia, Blood-Borne Infections, +16 more
Locations: Not specified

View Trial Details

Completed

A Study to Evaluate the Safety and Effectiveness of Epoetin Alfa in AIDS Patients With Anemia Caused Both by Their Disease and by AZT (Zidovudine, an Antiviral Drug) Given as Treatment for Their Disease

NCT00269945

Conditions: Acquired Immunodeficiency Syndrome, Anemia, Blood-Borne Infections, +16 more
Locations: Not specified

View Trial Details

Completed

A Study to Evaluate the Safety and Efficacy of Epoetin Alfa Versus Placebo for the Treatment of Anemia in Patients With Acquired Immunodeficiency Syndrome (AIDS) Who Are Receiving Zidovudine (AZT) Therapy

NCT00270283

Conditions: Acquired Immunodeficiency Syndrome, Anemia, Blood-Borne Infections, +16 more
Locations: Not specified

View Trial Details

Completed

KALETRA Or LEXIVA With Ritonavir Combined With EPIVIR And Abacavir In Naive Subjects Over 48 Weeks

NCT00085943

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +15 more
Locations: GSK Investigational Site Birmingham, Alabama, United States

GSK Investigational Site Phoenix, Arizona, United States

GSK Investigational Site Los Angeles, California, United States

GSK Investigational Site Sacramento, California, United States

View all 119 locations

View Trial Details